WCG Executive and Leadership Team

Terri Moench, the President, Clinical Research Solutions at WCG, directs the operational delivery of core clinical trial services. Overseeing the execution of research protocols, the President, Clinical Research Solutions ensures that biopharmaceutical companies and institutions meet stringent quality standards. This leadership role involves managing large-scale service teams to facilitate the development of new therapies across diverse therapeutic areas. Terri Moench drives operational excellence by streamlining trial processes and reducing administrative burdens for research sites. Through the implementation of best practices, the President, Clinical Research Solutions enhances the overall efficiency of the clinical development lifecycle. By coordinating with other C-suite leaders, Moench ensures that service delivery remains aligned with the company's strategic goals. Ultimately, the President, Clinical Research Solutions secures the successful execution of complex trials, directly contributing to the rapid advancement of medical treatments for patients worldwide.

Cynthia Carter, the President, MI & I at WCG, directs the market intelligence and innovation division to provide actionable insights for clinical trial stakeholders. Overseeing the analysis of complex research data, the President, MI & I ensures that clients receive precise information to guide trial design and site selection. This leadership role involves architecting innovative solutions that address the evolving challenges within the biopharmaceutical industry. Cynthia Carter drives the integration of advanced analytics into the company's service portfolio, enabling more informed decision-making for global research programs. Through the development of proprietary intelligence tools, the President, MI & I enhances the company's ability to predict and mitigate trial risks. By collaborating with cross-functional teams, Carter ensures that innovation remains at the forefront of the organization's strategy. Ultimately, the President, MI & I secures a competitive advantage by delivering high-value insights that accelerate the development of new treatments and therapies.

Paul Mancinelli, the Chief Technology Officer at WCG, directs the digital architecture supporting complex clinical trial workflows. By architecting scalable cloud infrastructure, the Chief Technology Officer ensures seamless data integration for biopharmaceutical partners across North American and European markets. This leadership role involves overseeing cybersecurity protocols and software development lifecycles to maintain rigorous compliance standards. Paul Mancinelli drives the implementation of advanced analytics platforms, enabling faster decision-making for research institutions. Through the modernization of internal systems, the Chief Technology Officer optimizes operational efficiency, directly impacting the speed of new treatment development. By aligning technical roadmaps with corporate objectives, Mancinelli secures the technological foundation necessary for long-term innovation. This focus on digital transformation empowers the entire organization to manage large-scale data sets with precision, ultimately supporting the mission of improving patient outcomes through superior technological capabilities.

Michael Passanante, the Chief Marketing Officer at WCG, directs global brand positioning and market engagement strategies for clinical trial services. Overseeing the development of value-driven messaging, the Chief Marketing Officer ensures alignment with the needs of CROs and biopharmaceutical clients. This leadership role involves executing multi-channel campaigns that highlight the efficiency gains provided by the company's research solutions. Michael Passanante drives market penetration by analyzing industry trends and competitive landscapes across international territories. Through the creation of thought leadership content, the Chief Marketing Officer builds authority within the R&D sector, fostering stronger connections with key stakeholders. By optimizing the marketing funnel, Passanante directly impacts lead generation and corporate growth. Ultimately, the Chief Marketing Officer secures a dominant market presence, ensuring that the company remains the preferred partner for institutions seeking to accelerate the development of life-saving therapies and medical treatments.

Antonio Castillo, the Director, Chief Revenue Officer Partnerships at WCG, directs strategic alliances and revenue-generating collaborations across the clinical research ecosystem. Overseeing the expansion of partner networks, the Director, Chief Revenue Officer Partnerships ensures that biopharmaceutical companies gain access to integrated service offerings. This leadership role involves negotiating complex agreements that drive sustainable financial growth and market reach. Antonio Castillo drives the alignment of partnership goals with the broader corporate mission of improving trial quality. By fostering long-term relationships with CROs and academic institutions, the Director, Chief Revenue Officer Partnerships secures a robust pipeline of collaborative opportunities. Through the systematic evaluation of partnership performance, Castillo optimizes revenue streams and enhances service delivery. Ultimately, the Director, Chief Revenue Officer Partnerships strengthens the company's competitive position by building a cohesive network of industry allies dedicated to advancing the development of new medical treatments and therapies.